Recent Expansion: Indianapolis Plant Novartis Pharma AG expanded its facilities to Indianapolis, USA, with a new manufacturing plant. This presents an opportunity to engage with local healthcare providers for potential collaborations and supply agreements.
Strategic Partnership with Clarius Mobile Health Corp The partnership between Novartis Pharma AG and Clarius Mobile Health Corp showcases a focus on innovative healthcare solutions. This collaboration opens doors for joint product offerings and market expansion opportunities in the healthcare technology sector.
Investment Inflows: Financial Design Group & Merit Financial Receiving investments from Financial Design Group and Merit Financial indicates confidence in Novartis' growth trajectory. Leveraging these financial partnerships can lead to enhanced sales strategies and potential expansion into new markets.
Partnership with Apontis Pharma AG in Germany Partnering with Apontis Pharma AG for distribution and marketing of asthma medications in Germany signifies an entry into a new market segment. This collaboration offers the chance to tap into the German pharmaceutical market and establish a stronger customer base.
Acquisition by Cetera Financial Group The acquisition of Novartis Pharma AG by Cetera Financial Group might lead to synergies in the financial and healthcare sectors. Exploring cross-selling opportunities with Cetera's network could result in increased sales and business growth.
Novartis uses 8 technology products and services including Google Analytics 4, Iron Mountain, QlikView, and more. Explore Novartis's tech stack below.
| Novartis Email Formats | Percentage |
| first.last@novartis.com | 91% |
| f.last@novartis.com | 4% |
| flast@novartis.com | 4% |
| first.l@novartis.com | 1% |
| first.last@group.novartis.com | 84% |
| last@group.novartis.com | 12% |
| last.first@group.novartis.com | 4% |
| first.last@pharma.novartis.com | 90% |
| last.first@pharma.novartis.com | 1% |
| first.middlelast@pharma.novartis.com | 1% |
| f_last@pharma.novartis.com | 0% |
| last.f@pharma.novartis.com | 1% |
| flast@pharma.novartis.com | 0% |
| lastfi@pharma.novartis.com | 1% |
| f.last@pharma.novartis.com | 0% |
| first.middle@pharma.novartis.com | 0% |
| last_first@pharma.novartis.com | 1% |
| first-last@pharma.novartis.com | 0% |
| firstl@pharma.novartis.com | 1% |
| firstlas@pharma.novartis.com | 0% |
| lastfir@pharma.novartis.com | 0% |
| firstla@pharma.novartis.com | 1% |
| lastf@pharma.novartis.com | 0% |
| firstlast@pharma.novartis.com | 1% |
| f-last@pharma.novartis.com | 0% |
| first_last@pharma.novartis.com | 0% |
| firlast@pharma.novartis.com | 1% |
| lastfirst@pharma.novartis.com | 0% |
| filast@pharma.novartis.com | 0% |
| firstmiddle.last@pharma.novartis.com | 1% |
| fir.last@pharma.novartis.com | 0% |
| last@pharma.novartis.com | 0% |
Pharmaceutical ManufacturingBaselstadt, Switzerland10001+ Employees
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
Company Overview
Media & News
Funding & FinancialsNovartis has raised a total of $6.5M of funding over 1 rounds. Their latest funding round was raised on Feb 14, 2018.
Novartis's revenue is in the range of $1B
Funding & FinancialsNovartis has raised a total of $6.5M of funding over 1 rounds. Their latest funding round was raised on Feb 14, 2018.
Novartis's revenue is in the range of $1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com